Overview

Apremilast in the Treatment of Uveitis

Status:
Terminated
Trial end date:
2011-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety and efficacy of Apremilast in the treatment of uveitis.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Oregon Health and Science University
Collaborator:
Celgene Corporation
Treatments:
Apremilast
Thalidomide